United States · FDA National Drug Code directory
Acyclovir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-7275_810fa4f4-8281-44c0-98c2-a3cc70098fab
- Product NDC
- 50090-7275
- Form
- TABLET
- Composition / generic term
- Acyclovir
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230620
- Source listing expiry
- 20261231
Source-listed ingredients
- ACYCLOVIR — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 25 TABLET in 1 BOTTLE (50090-7275-2) · 50090-7275-2
- 50 TABLET in 1 BOTTLE (50090-7275-3) · 50090-7275-3
- 15 TABLET in 1 BOTTLE (50090-7275-4) · 50090-7275-4
- 30 TABLET in 1 BOTTLE (50090-7275-5) · 50090-7275-5
- 60 TABLET in 1 BOTTLE (50090-7275-6) · 50090-7275-6
- 45 TABLET in 1 BOTTLE (50090-7275-9) · 50090-7275-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →